Stay updated on Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.

Latest updates to the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page
- Check6 days agoChange DetectedThe 'Last Update Posted' label has been changed to 'Last Update Posted (Estimated)' to indicate the timestamp is an estimate. The previous plain label 'Last Update Posted' has been removed.SummaryDifference0.0%

- Check13 days agoChange DetectedStudy Details page now shows status 'Active, not recruiting' and a 'Last Update Posted' date; outdated 'Recruiting' text and contact details (e.g., Study Coordinator, phone) were removed.SummaryDifference0.3%

- Check20 days agoChange DetectedChanged the Study Record Dates label from 'Last Update Posted' to 'Last Update Posted (Estimated)'; this is a minor formatting change that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%

- Check48 days agoChange DetectedAdded numerous contact phone numbers and the new software revision v3.1.0; removed the old revision v3.0.2. The update primarily signals updated contact options and a version bump.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded September 2025 release notes (Revision: v3.0.2) and removed August 2025 notes (Revision: v3.0.1) plus the Back to Top link.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.